DDX3X and breast carcinoma: Along these lines, DDX3 has been shown to be associated with Hypoxia and an anti-apoptotic complex within the context of TRAIL-R2 resistant MDA-MB-231, which is well established as an aggressive breast cancer cell line19, 42.